Clinical Trials Directory

Trials / Completed

CompletedNCT02503254

Reduced Exposure Study Using CHTP 1.0 During 5 Days in Confinement.

A Randomized, Controlled, Open-label, 2-arm Parallel Group, Single Center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Healthy Smokers Switching to the Carbon Heated Tobacco Product 1.0 (CHTP 1.0) Compared to Continuing to Use Conventional Cigarettes During 5 Days in Confinement.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
85 (actual)
Sponsor
Philip Morris Products S.A. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

The overall goal of the study is to demonstrate the reduction of biomarkers of exposure (BoExp) to selected harmful and potentially harmful constituents (HPHCs) in adult smokers switching for 5 days from conventional cigarette (CC) to Carbon Heated Tobacco Product 1.0 (CHTP 1.0) as compared to smokers continuing to use CC.

Conditions

Interventions

TypeNameDescription
OTHERCHTP 1.0CHTP 1.0 ad libitum for 5 days in confinement
OTHERConventional Cigarette (CC)Subject's own preferred brand of CC ad libitum for 5 days in confinement

Timeline

Start date
2015-07-01
Primary completion
2015-09-01
Completion
2016-03-01
First posted
2015-07-20
Last updated
2023-01-30
Results posted
2017-03-10

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT02503254. Inclusion in this directory is not an endorsement.

Reduced Exposure Study Using CHTP 1.0 During 5 Days in Confinement. (NCT02503254) · Clinical Trials Directory